Get the brief by email

One short read every morning. Free.

← Latest edition

Brief'd Daily

Trump claims Iran deal, ECB raises rates, SpaceX IPO trades

2026-06-12

Trump Declares Iran Settlement as US Shoots Down Drones; CPI Hits 3-Year High at 4.2% Amid Energy Surge

President Trump announced a "great settlement" with Iran to end a 100-day conflict, claiming a deal could be signed within days, while simultaneously US forces shot down Iranian drones over the Strait of Hormuz and Iran's military retaliated against US bases. The conflict has driven inflation sharply higher, with May's Consumer Price Index rising 4.2% annually—the fastest pace in three years—driven almost entirely by energy costs spiking 23.5% year-over-year as Middle Eastern oil supplies face disruption.

ECB raises rates for first time since 2023 as Middle East war fuels inflation; Fed expected to hold steady on June 17

The European Central Bank raised its benchmark deposit rate by 25 basis points to 2.25% on June 11, citing inflation pressures driven by energy shocks from the Iran war, while revising inflation forecasts sharply upward. The move sets up a sharp divergence with the U.S. Federal Reserve, which is widely expected to hold rates unchanged at its June 17-18 meeting despite similar inflationary pressures.

Europe's Record Heatwave Intensifies Climate Pressure as UN Warns 1.5°C Overshoot 'Almost Inevitable'

Europe experienced record-breaking temperatures in late May, with parts of Spain, UK, Germany, France, and Ireland seeing heatwaves 10-15°C above normal, coinciding with UN climate talks in Bonn. Scientists and UN officials warned that a temporary overshoot of the 1.5°C warming threshold is now almost inevitable, as the past three years have already exceeded that threshold and emissions cuts continue to lag behind what's needed.

EU proposes 21st sanctions package targeting Lukoil, Rosneft, 90 banks, and shadow fleet ahead of July 15 vote

The European Commission unveiled a sweeping 21st sanctions package against Russia targeting energy giants Lukoil and Rosneft, 90 banks, 30 additional shadow fleet vessels, and introducing first-ever restrictions on fisheries and cryptocurrency services. The measures, proposed by Commission President von der Leyen and EU High Representative Kallas, require unanimous approval from EU member states by mid-summer and aim to maintain economic pressure on Russia's war economy.

Ukraine approves record UAH 4.4 trillion defense budget with EU backing as drone campaign cripples Crimea supply lines

Ukraine's parliament passed a UAH 1.56 trillion increase to the 2026 defense budget, bringing total defense spending to a record UAH 4.4 trillion, funded partly by a €90 billion EU loan. The vote coincides with a major Ukrainian drone campaign that has reduced Russian military cargo traffic to Crimea by 71% and destroyed the critical Chonhar Bridge.

SpaceX begins trading on Nasdaq under ticker SPCX, raising $75B at $1.75T valuation in largest IPO in recorded history

SpaceX completed the largest IPO in history on June 12, 2026, raising $75 billion at a $1.75 trillion valuation and beginning trading on Nasdaq under ticker SPCX. The offering dwarfs the previous record holder Saudi Aramco's $29.4 billion IPO and makes SpaceX the seventh most-valuable U.S. company, while retail investors showed exceptional demand of $100 billion in orders despite receiving a smaller-than-expected allocation.

Gilead and Merck's once-weekly HIV pill islatravir/lenacapavir meets Phase 3 trial endpoints, on track to be first approved long-acting oral treatment

Gilead Sciences and Merck announced on June 8, 2026, that their investigational once-weekly oral HIV treatment combining islatravir and lenacapavir met primary efficacy endpoints in both Phase 3 ISLEND trials, maintaining viral suppression at Week 48 and proving non-inferior to daily regimens. If approved, the single-tablet combination would be the first long-acting oral HIV treatment requiring only once-weekly dosing, potentially improving treatment adherence for millions of patients.

World's largest opioid review finds widely prescribed painkillers no better than placebo for most acute pain conditions

A comprehensive review of 59 systematic studies led by University of Sydney researchers found that opioids deliver only small, short-lived pain relief for most acute pain conditions and often perform no better than placebo. The study, covering over 50 acute pain conditions, also documented higher rates of side effects including nausea and vomiting, and warned that dependence can develop after short-term use.

Spielberg's sci-fi thriller 'Disclosure Day' opens in U.S. theaters with strong reviews and box office expectations

Steven Spielberg's 'Disclosure Day,' starring Emily Blunt and Josh O'Connor, premiered in U.S. theaters on June 12, 2026, to largely positive critical reception and strong box office forecasts. The science fiction thriller follows a cybersecurity whistleblower and TV meteorologist uncovering a government conspiracy to conceal evidence of extraterrestrial encounters.

Prefer to listen?

Past editions